Annual Drug Patent Expirations for MYRBETRIQ+GRANULES
Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
Drug patent litigation for MYRBETRIQ GRANULES.
This drug has fifty-two patent family members in twenty-two countries.
The generic ingredient in MYRBETRIQ GRANULES is mirabegron. One supplier is listed for this compound. Additional details are available on the mirabegron profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
